Soligenix SNGX
$ 3.67
-1.61%
Quarterly report 2024-Q2
added 08-09-2024
Soligenix Balance Sheet 2011-2024 | SNGX
Annual Balance Sheet Soligenix
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-7.31 M | -13 M | - | -8.17 M | -5.29 M | -8.98 M | -7.81 M | -8.77 M | -4.63 M | -1.74 M | -5.86 M | -3.36 M | -6 M |
Long Term Debt |
1.01 M | 234 K | - | 9.95 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
122 K | 109 K | 106 K | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 10.1 M | 6.15 K | - | - | - | - | - | - | - | - |
Total Current Liabilities |
6.15 M | 16.5 M | 6.29 M | 6.08 M | 6.31 M | 4.21 M | 3.23 M | 2.87 M | 7.41 M | 7.11 M | 10 M | 1.15 M | 1.43 M |
Total Liabilities |
7.27 M | 16.8 M | 16.1 M | 16.1 M | 6.32 M | 4.21 M | 3.23 M | 2.87 M | 7.41 M | 7.11 M | 10 M | 1.15 M | 1.43 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-226 M | -220 M | -206 M | -193 M | -176 M | -166 M | -157 M | -150 M | -147 M | -139 M | -132 M | -122 M | -118 M |
Total Assets |
9.8 M | 14.3 M | 26.9 M | 19.9 M | 7.78 M | 10.5 M | 9.55 M | 10.3 M | 7.39 M | 6.95 M | 8.27 M | 4.71 M | 8.22 M |
Cash and Cash Equivalents |
8.45 M | 13.4 M | 26 M | 18.7 M | 5.42 M | 8.98 M | 7.81 M | 8.77 M | 4.92 M | 5.53 M | 5.86 M | 3.36 M | 6 M |
Book Value |
2.52 M | -2.47 M | 10.7 M | 3.74 M | 1.46 M | 6.28 M | 6.32 M | 7.4 M | -18.3 K | -154 K | -1.77 M | 3.55 M | 6.79 M |
Total Shareholders Equity |
2.52 M | -2.47 M | 10.7 M | 3.74 M | 1.46 M | 6.28 M | 6.32 M | 7.4 M | -18.3 K | -154 K | -1.77 M | 3.55 M | 6.79 M |
All numbers in USD currency
Quarterly Balance Sheet Soligenix
2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
45.7 K | 1.01 M | 1.42 M | 2.09 M | 204 K | 234 K | 262 K | 290 K | - | - | - | - | 10 M | 10 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
6.4 M | 7.27 M | 7.08 M | 8.03 M | 14.5 M | 16.8 M | 16.9 M | 17.1 M | 17.1 M | 16.1 M | 14.7 M | 14 M | 14.2 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 6.32 M | 6.32 M | 6.32 M | 6.32 M | 4.21 M | 4.21 M | 4.21 M | 4.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | 100 K | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-229 M | -226 M | -224 M | -222 M | -221 M | -220 M | -216 M | -213 M | -210 M | -206 M | -201 M | -197 M | -196 M | -193 M | -193 M | -193 M | -193 M | -176 M | -176 M | -176 M | -176 M | -166 M | -166 M | -166 M | -166 M | -157 M | -157 M | -157 M | -157 M | -150 M | -150 M | -150 M | -150 M | -147 M | -147 M | -147 M | -147 M | -139 M | -139 M | -139 M | -139 M | -132 M | -132 M | -132 M | -132 M | -122 M | -122 M | -122 M | -122 M | -118 M | -118 M | -118 M | -118 M |
Total Assets |
9.87 M | 9.8 M | 11.3 M | 13.8 M | 11.1 M | 14.3 M | 17.9 M | 21.3 M | 23.7 M | 26.9 M | 29.7 M | 29.6 M | 31.6 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 7.78 M | 7.78 M | 7.78 M | 7.78 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 9.55 M | 9.55 M | 9.55 M | 9.55 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 7.39 M | 7.39 M | 7.39 M | 7.39 M | 6.95 M | 6.95 M | 6.95 M | 6.95 M | 8.27 M | 8.27 M | 8.27 M | 8.27 M | 4.71 M | 4.71 M | 4.71 M | 4.71 M | 8.22 M | 8.22 M | 8.22 M | 8.22 M |
Cash and Cash Equivalents |
9.41 M | 8.45 M | 10.3 M | 13.2 M | 10.3 M | 13.4 M | 16.9 M | 20.2 M | 22.9 M | 26 M | 28.9 M | 29 M | 30.5 M | 18.7 M | 18.7 M | 18.7 M | 18.7 M | 5.42 M | 5.42 M | 5.42 M | 5.42 M | 8.98 M | 8.98 M | 8.98 M | 8.98 M | 7.81 M | 7.81 M | 7.81 M | 7.81 M | 8.77 M | 8.77 M | 8.77 M | 8.77 M | 4.92 M | 4.92 M | 4.92 M | 4.92 M | 5.53 M | 5.53 M | 5.53 M | 5.53 M | 5.86 M | 5.86 M | 5.86 M | 5.86 M | 3.36 M | 3.36 M | 3.36 M | 3.36 M | 6 M | 6 M | 6 M | 6 M |
Book Value |
3.46 M | 2.52 M | 4.22 M | 5.8 M | -3.39 M | -2.47 M | 1.03 M | 4.21 M | 6.58 M | 10.7 M | 15.1 M | 15.6 M | 17.3 M | 3.74 M | 3.74 M | 3.74 M | 3.74 M | 1.46 M | 1.46 M | 1.46 M | 1.46 M | 6.28 M | 6.28 M | 6.28 M | 6.28 M | 9.55 M | 9.55 M | 9.55 M | 9.55 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 7.39 M | 7.39 M | 7.39 M | 7.39 M | 6.95 M | 6.95 M | 6.95 M | 6.95 M | 8.27 M | 8.27 M | 8.27 M | 8.27 M | 4.71 M | 4.71 M | 4.71 M | 4.71 M | 8.22 M | 8.22 M | 8.22 M | 8.22 M |
Total Shareholders Equity |
3.46 M | 2.52 M | 4.22 M | 5.8 M | -3.39 M | -2.47 M | 1.03 M | 4.21 M | 6.58 M | 10.7 M | 15.1 M | 15.6 M | 17.3 M | 3.74 M | 3.74 M | 3.74 M | 3.74 M | 1.46 M | 1.46 M | 1.46 M | 1.46 M | 6.28 M | 6.28 M | 6.28 M | 6.28 M | 6.32 M | 6.32 M | 6.32 M | 6.32 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | -18.3 K | -18.3 K | -18.3 K | -18.3 K | -154 K | -154 K | -154 K | -154 K | -1.77 M | -1.77 M | -1.77 M | -1.77 M | 3.55 M | 3.55 M | 3.55 M | 3.55 M | 6.79 M | 7.5 M | 6.79 M | 6.79 M |
All numbers in USD currency